Cetuximab Plus Irinotecan Versus Panitumumab in Patients With Refractory Metastatic Colorectal Cancer in Ontario, Canada

International Journal of Cancer - United States
doi 10.1002/ijc.30637
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley